<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:05:08Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5464963" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5464963</identifier><datestamp>2017-06-16</datestamp><setSpec>elsevierwt</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cell Rep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Cell Rep</journal-id>
      <journal-title-group>
        <journal-title>Cell Reports</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2211-1247</issn>
      <publisher>
        <publisher-name>Cell Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5464963</article-id>
      <article-id pub-id-type="pmcid">PMC5464963</article-id>
      <article-id pub-id-type="pmc-uid">5464963</article-id>
      <article-id pub-id-type="pmid">28564608</article-id>
      <article-id pub-id-type="publisher-id">S2211-1247(17)30636-8</article-id>
      <article-id pub-id-type="doi">10.1016/j.celrep.2017.05.011</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Structural Basis of the Human Endoglin-BMP9 Interaction: Insights into BMP Signaling and HHT1</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Saito</surname>
            <given-names>Takako</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn1" ref-type="fn">5</xref>
          <xref rid="fn2" ref-type="fn">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bokhove</surname>
            <given-names>Marcel</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn2" ref-type="fn">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Croci</surname>
            <given-names>Romina</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zamora-Caballero</surname>
            <given-names>Sara</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Han</surname>
            <given-names>Ling</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Letarte</surname>
            <given-names>Michelle</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Sanctis</surname>
            <given-names>Daniele</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jovine</surname>
            <given-names>Luca</given-names>
          </name>
          <email>luca.jovine@ki.se</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn3" ref-type="fn">7</xref>
          <xref rid="cor1" ref-type="corresp">â</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Department of Biosciences and Nutrition and Center for Innovative Medicine, Karolinska Institutet, Huddinge 14183, Sweden</aff>
      <aff id="aff2"><label>2</label>Molecular Medicine, Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, University of Toronto, Toronto, ON M5G 0A4, Canada</aff>
      <aff id="aff3"><label>3</label>Department of Immunology, University of Toronto, Toronto, ON M5G 0A4, Canada</aff>
      <aff id="aff4"><label>4</label>ESRFâThe European Synchrotron, Grenoble 38000, France</aff>
      <author-notes>
        <corresp id="cor1"><label>â</label>Corresponding author <email>luca.jovine@ki.se</email></corresp>
        <fn id="fn1">
          <label>5</label>
          <p id="ntpara0010">Present address: Department of Cell Science, Institute of Biomedical Sciences, School of Medicine, Fukushima Medical University, Fukushima 9601295, Japan</p>
        </fn>
        <fn id="fn2">
          <label>6</label>
          <p id="ntpara0015">These authors contributed equally</p>
        </fn>
        <fn id="fn3">
          <label>7</label>
          <p id="ntpara0020">Lead Contact</p>
        </fn>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>30</day>
        <month>5</month>
        <year>2017</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
      <pub-date pub-type="collection">
        <day>30</day>
        <month>5</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>5</month>
        <year>2017</year>
      </pub-date>
      <volume>19</volume>
      <issue>9</issue>
      <fpage>1917</fpage>
      <lpage>1928</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>12</month>
          <year>2016</year>
        </date>
        <date date-type="rev-recd">
          <day>30</day>
          <month>3</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>2</day>
          <month>5</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2017 The Author(s)</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
          <license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
        </license>
      </permissions>
      <abstract id="abs0010">
        <title>Summary</title>
        <p>Endoglin (ENG)/CD105 is an essential endothelial cellÂ co-receptor of the transforming growth factor Î² (TGF-Î²) superfamily, mutated in hereditary hemorrhagic telangiectasia type 1 (HHT1) and involved in tumor angiogenesis and preeclampsia. Here, we present crystal structures of the ectodomain of human ENG and its complex with the ligand bone morphogenetic protein 9 (BMP9). BMP9 interacts with a hydrophobic surface of the N-terminal orphan domain of ENG, which adopts a new duplicated fold generated by circular permutation. The interface involves residues mutated in HHT1 and overlaps with the epitope of tumor-suppressing anti-ENG monoclonal TRC105. The structure of the C-terminal zona pellucida module suggests how two copies of ENG embrace homodimeric BMP9, whose binding is compatible with ligand recognition by type I but not type II receptors. These findings shed light on the molecular basis of the BMP signaling cascade, with implications for future therapeutic interventions in this fundamental pathway.</p>
      </abstract>
      <abstract abstract-type="graphical" id="abs0015">
        <title>Graphical Abstract</title>
        <fig id="undfig1" position="anchor">
          <graphic xlink:href="fx1"/>
        </fig>
      </abstract>
      <abstract abstract-type="author-highlights" id="abs0020">
        <title>Highlights</title>
        <p>
          <list list-type="simple">
            <list-item id="u0010">
              <label>â¢</label>
              <p>Crystal structures of human ENG and its complex with BMP9 were determined</p>
            </list-item>
            <list-item id="u0015">
              <label>â¢</label>
              <p>The orphan domain of ENG adopts a fold that explains the effect of HHT1 mutations</p>
            </list-item>
            <list-item id="u0020">
              <label>â¢</label>
              <p>ZP module-mediated dimerization of ENG creates a clamp that secures homodimeric BMP9</p>
            </list-item>
            <list-item id="u0025">
              <label>â¢</label>
              <p>ENG-bound BMP9 can interact with the ALK1 receptor but not the ActRIIB receptor</p>
            </list-item>
          </list>
        </p>
      </abstract>
      <abstract abstract-type="teaser" id="abs0025">
        <p>Endoglin (ENG)/CD105, a key player in angiogenesis and vascular homeostasis, is mutated in the genetic disorder HHT1 and implicated in tumor angiogenesis and preeclampsia. Saito etÂ al. determine structures of human ENG alone and in complex with the physiological ligand BMP9, shedding light onto the molecular basis of BMP signaling.</p>
      </abstract>
      <kwd-group id="kwrds0010">
        <title>Keywords</title>
        <kwd>bone morphogenetic protein receptors</kwd>
        <kwd>cell surface receptors</kwd>
        <kwd>endoglin</kwd>
        <kwd>growth differentiation factor 2</kwd>
        <kwd>hereditary hemorrhagic telangiectasia</kwd>
        <kwd>orphan domain</kwd>
        <kwd>protein interaction domains and motifs</kwd>
        <kwd>TGF-Î² superfamily proteins</kwd>
        <kwd>x-ray crystallography</kwd>
        <kwd>zona pellucida domain</kwd>
      </kwd-group>
    </article-meta>
    <notes>
      <p id="misc0010">Published: May 30, 2017</p>
    </notes>
  </front>
  <body>
    <sec id="sec1">
      <title>Introduction</title>
      <p>The transforming growth factor Î² (TGF-Î²) superfamily consists of type I and II serine/threonine kinase receptors that interact with structurally related ligands, including TGF-Î²s and bone morphogenetic proteins (BMPs). Ligand-induced receptor complex formation results in phosphorylation of a type I receptor by a type II receptor, which, in turn, leads to phosphorylation of one of several downstream Smad proteins and signal transduction (<xref rid="bib29" ref-type="bibr">Horbelt etÂ al., 2012</xref>).</p>
      <p>ENG is an abundant type I transmembrane glycoprotein of the vascular endothelium that was initially recognized as a co-receptor for TGF-Î²1 and TGF-Î²3, associating with TGF-Î² type I and II receptors (<xref rid="bib16" ref-type="bibr">Cheifetz etÂ al., 1992</xref>, <xref rid="bib20" ref-type="bibr">Gougos and Letarte, 1988a</xref>, <xref rid="bib22" ref-type="bibr">Gougos and Letarte, 1990</xref>, <xref rid="bib48" ref-type="bibr">Quackenbush and Letarte, 1985</xref>). In most cells, the TGF-Î² type I receptor is activin receptor-like kinase 5 (ALK5), whereas, in endothelial cells, there is also ALK1. ENG and ALK1 were subsequently shown to bind with much higher affinity to BMP9 (also known as growth differentiation factor 2 [GDF2]) than to TGF-Î²1 and mediate its proliferation signal (<xref rid="bib13" ref-type="bibr">Brown etÂ al., 2005</xref>, <xref rid="bib43" ref-type="bibr">Nolan-Stevaux etÂ al., 2012</xref>, <xref rid="bib51" ref-type="bibr">Scharpfenecker etÂ al., 2007</xref>). Post-translationally processed homodimeric BMP9 mediates signal transduction via a set of interactions involving ENG, ALK1, and a BMP type II receptor (BMPRII or ActRIIB) (<xref rid="bib9" ref-type="bibr">Bidart etÂ al., 2012</xref>, <xref rid="bib13" ref-type="bibr">Brown etÂ al., 2005</xref>, <xref rid="bib17" ref-type="bibr">David etÂ al., 2007</xref>, <xref rid="bib31" ref-type="bibr">Kienast etÂ al., 2016</xref>, <xref rid="bib51" ref-type="bibr">Scharpfenecker etÂ al., 2007</xref>, <xref rid="bib55" ref-type="bibr">Upton etÂ al., 2009</xref>). Like ALK1, ENG is essential for heart development and vascular homeostasis; <italic>Eng</italic><sup>â/â</sup> mice die at mid-gestation because of defective cardiovascular development and angiogenesis (<xref rid="bib12" ref-type="bibr">Bourdeau etÂ al., 1999</xref>, <xref rid="bib33" ref-type="bibr">Li etÂ al., 1999</xref>). ENG is overexpressed in the vascular endothelium of solid tumors (<xref rid="bib8" ref-type="bibr">Bernabeu etÂ al., 2009</xref>, <xref rid="bib41" ref-type="bibr">Miller etÂ al., 1999</xref>), and functionally blocking antibodies to ENGÂ can inhibit tumor growth via the ENG/BMP9/ALK1 pathway (<xref rid="bib32" ref-type="bibr">Lebrin etÂ al., 2004</xref>). Mutations in the <italic>ENG</italic> gene cause the autosomal dominant disorder hereditary hemorrhagic telangiectasia typeÂ 1Â (HHT1), a vascular dysplasia with life-threatening consequences that affects 1 in 10,000 individuals and is characterized byÂ arteriovenous malformations, recurrent hemorrhages, and numerous sequelae (<xref rid="bib1" ref-type="bibr">Abdalla and Letarte, 2006</xref>, <xref rid="bib12" ref-type="bibr">Bourdeau etÂ al., 1999</xref>, <xref rid="bib39" ref-type="bibr">McAllister etÂ al., 1994</xref>). Over 500 human <italic>ENG</italic> gene variants linked to HHT1 are currently reported in the University of Utah Department of Pathology HHT and ENG Database (<ext-link ext-link-type="uri" xlink:href="http://www.arup.utah.edu/database/ENG/ENG_welcome.php" id="intref0010">http://www.arup.utah.edu/database/ENG/ENG_welcome.php</ext-link>; <xref rid="bib53" ref-type="bibr">Stenson etÂ al., 2014</xref>). Moreover, a circulating form of the ENG ectodomain, suggested to be released upon C-terminal cleavage of ENG by matrix metalloproteinase 14 (MMP-14) (<xref rid="bib27" ref-type="bibr">Hawinkels etÂ al., 2010</xref>), is increased at early stages of preeclampsia and serves as a predictive marker (<xref rid="bib24" ref-type="bibr">Gregory etÂ al., 2014</xref>, <xref rid="bib57" ref-type="bibr">Venkatesha etÂ al., 2006</xref>). Despite the important role of ENG in the vascular system, its association with several diseases and potential use as a target of anti-angiogenic cancer therapy (<xref rid="bib8" ref-type="bibr">Bernabeu etÂ al., 2009</xref>, <xref rid="bib45" ref-type="bibr">Paauwe etÂ al., 2016</xref>), no high-resolution structural information is available for the protein and how it interacts with the key ligand BMP9 (<xref rid="bib14" ref-type="bibr">Castonguay etÂ al., 2011</xref>).</p>
      <p>ENG is predominantly expressed as an â¼180 kDa homodimer linked by intermolecular disulfide bonds (<xref rid="bib21" ref-type="bibr">Gougos and Letarte, 1988b</xref>, <xref rid="bib22" ref-type="bibr">Gougos and Letarte, 1990</xref>). It is composed of an N-terminal orphan region (OR), a C-terminal bipartite zona pellucida module (ZP), a single transmembrane domain, and a short cytoplasmic peptide that differs in the L and S isoforms of the protein (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S1</xref>A; <xref rid="bib7" ref-type="bibr">BellÃ³n etÂ al., 1993</xref>, <xref rid="bib8" ref-type="bibr">Bernabeu etÂ al., 2009</xref>, <xref rid="bib24" ref-type="bibr">Gregory etÂ al., 2014</xref>, <xref rid="bib35" ref-type="bibr">Litscher and Wassarman, 2015</xref>). Extensive attempts to crystallize the full-length ectodomain of ENG (ECTO; residues E26âG586), using different strategies to reduce N-glycan heterogeneity, were not successful. We reasoned that this may be caused by flexibility of the OR/ZP linker (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S1</xref>A, arrow), which could underlie the different conformations observed by small-angle X-ray scattering (<xref rid="bib4" ref-type="bibr">Alt etÂ al., 2012</xref>, <xref rid="bib56" ref-type="bibr">Van Le etÂ al., 2009</xref>) and negative stain electron microscopy (<xref rid="bib36" ref-type="bibr">Llorca etÂ al., 2007</xref>). To overcome this obstacle, we combined a divide and conquer strategy with a recently developed eukaryotic expression system where proteins of interest are fused to a mammalianized version of bacterial maltose-binding protein (mMBP) (<xref rid="bib10" ref-type="bibr">Bokhove etÂ al., 2016a</xref>). Using this approach, we first elucidated the crystal structure ofÂ ENG OR, which plays a key role in signaling by binding BMP9 (<xref rid="bib14" ref-type="bibr">Castonguay etÂ al., 2011</xref>) and does not show homology to proteins of known structure (<xref rid="bib4" ref-type="bibr">Alt etÂ al., 2012</xref>, <xref rid="bib36" ref-type="bibr">Llorca etÂ al., 2007</xref>); subsequently, we determined the structure of the OR-BMP9 complex as well as the structure of ENG ZP.</p>
      <p>The structure of ENG OR reveals a new fold wherein a Î² helix-like domain with an unprecedented topology has been duplicated, followed by circular permutation. The electron density map of ENG OR in complex with BMP9 shows how the knuckle region of the ligand interacts hydrophobically with a ridge at the edge of OR, including residues previously implicated in BMP9 binding (<xref rid="bib38" ref-type="bibr">Mallet etÂ al., 2015</xref>). Finally, the crystal structure of ENG ZP reveals a minimal fold with the short ZP-N/ZP-C interdomain linker signature of non-polymerizing ZP modules (<xref rid="bib11" ref-type="bibr">Bokhove etÂ al., 2016b</xref>). Based on the structures of OR and ZP, a model can be presented of the ENG disulfide-bonded dimer in complex with BMP9 and the type I receptor ALK1.</p>
    </sec>
    <sec id="sec2">
      <title>Results and Discussion</title>
      <sec id="sec2.1">
        <title>The Crystal Structure of OR Reveals Two Intertwined Domains</title>
        <p>The structure of OR (ENG E26âS337) fused to mMBP (<sup>M</sup>OR; <xref rid="mmc1" ref-type="supplementary-material">Figures S1</xref>B and <xref rid="mmc1" ref-type="supplementary-material">S2</xref>AâS2C) was solved at 2.4 Ã resolution by molecular replacement (MR) with MBP (<xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>). The electron density map (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S2</xref>B<italic>)</italic> reveals that OR is a monomer and consists of two domains that share a common new fold (OR1/OR2; <xref rid="fig1" ref-type="fig">FigureÂ 1</xref>). Each domain consists of 12 Î² strands, which form a parallel Î² helix-like structure, and a single Î± helix. Interestingly, OR2 (Î²3âÎ²14 and Î±1) is inserted C-terminally to OR1 Î²1âÎ²2, after which OR1 (Î²15âÎ²24 and Î±2) is completed (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>B). Both domains contain a conserved disulfide bond involving C30âC207 and C53âC182, respectively (<xref rid="fig1" ref-type="fig">Figures 1</xref>Aâ1C; <xref rid="mmc1" ref-type="supplementary-material">FigureÂ S2</xref>D). Two additional Cys in OR1, C242 and C330 (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S1</xref>A), are likely to form a third disulfide that is not resolved because of structural disorder of residuesÂ S329âS337. However, an <sup>M</sup>OR variant lacking both Cys is secreted as efficiently as wild-type <sup>M</sup>OR and retains BMP9 binding activity, indicating that C242 and C330 are not crucial for folding and interaction with the ligand (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S1</xref>C).<fig id="fig1"><label>FigureÂ 1</label><caption><p>ENG OR Consists of a Duplicated and Circularly Permutated Domain</p><p>(A) Cartoon representation of the OR crystal structure, consisting of two domains (OR1/OR2) and rainbow-colored from blue (N terminus) to red (C terminus). Cys residues are shown in ball-and-stick representation.</p><p>(B) OR topology with OR1 and OR2 Î² helices colored dark and light blue, respectively. Î² Strands (arrows) are numbered.</p><p>(C) Superposition of OR1 and OR2, colored as in (B).</p><p>(D) Suggested evolution of ENG OR by gene duplication and circular permutation.</p><p>(E) Superposition of ENG OR2 and tubulin cofactor C (TBCC).</p><p>See also <xref rid="mmc1" ref-type="supplementary-material">Figures S1âS3</xref> and <xref rid="mmc1" ref-type="supplementary-material">S6</xref> and <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>.</p></caption><graphic xlink:href="gr1"/></fig></p>
      </sec>
      <sec id="sec2.2">
        <title>OR Is a Result of Gene Duplication Followed by Circular Permutation</title>
        <p>OR1 and OR2 are only 18% identical in sequence but can be superimposed with a CÎ± root-mean-square deviation of 2.2Â Ã for 102 overlapping residues (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>C; <xref rid="mmc1" ref-type="supplementary-material">FigureÂ S3</xref>A). Although OR2 does not require OR1 for folding and secretion (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S3</xref>B), an OR1-only construct was not secreted by itself (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S3</xref>C). Notably, the relative sequence position of the Cys moieties of the conserved disulfide is reversed in OR1 compared with OR2 so that C30 and C207 correspond to C182 and C53, respectively. Moreover, the N-terminal sequence of OR1 (including strands Î²1 and Î²2) aligns with the C-terminal part of its OR2 domain (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S3</xref>A). Taken together, these observations suggest that OR1 was generated by a duplication of an ancestral OR2 gene, followed by circular permutation (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>D). Considering that ENG is only found in amniotes, a possible evolutionary relationship for OR2 may be, in turn, indicated by the fact that its structure distantly resembles tubulin cofactor C (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>E). However, this Î²-helical molecular chaperone has a markedly different topology with a C-terminal Î± helix (<xref rid="bib42" ref-type="bibr">Nithianantham etÂ al., 2015</xref>).</p>
      </sec>
      <sec id="sec2.3">
        <title>BMP9 Binds to a Conserved Hydrophobic Groove of OR1</title>
        <p>To gain insights into how ENG modulates signaling (including cell proliferation) by interacting with ligands, we co-expressed <sup>M</sup>OR and BMP9 in mammalian cells and crystallized the resulting complex (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S4</xref>A). Although the crystals only diffracted to â¼4.5Â Ã, the data could be phased by MR using mMBP, OR1, and an independently determined structure of BMP9 (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S4</xref>B; <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>). In the complex crystals, the disulfide-bonded BMP9 homodimer spans two adjacent asymmetric units by lying on a symmetry axis (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S4</xref>C), and the knuckle of each BMP9 molecule binds to a copy of OR1 (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S4</xref>D), resulting in a âdimer of heterodimersâ (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>A). This arrangement is consistent with co-expression experiments of His- and Myc-tagged <sup>M</sup>OR with BMP9 followed by His pull-down. Immunoblot analysis shows that Myc-<sup>M</sup>OR co-elutes with His-<sup>M</sup>OR only in the presence of BMP9, indicating that the dimeric ligand binds two copies of OR that do not interact with each other (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>B). In agreement with the fact that mMBP and BMP9 are positioned on opposite sides of OR1 in the crystals (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S4</xref>C), mMBP does not inhibit ENG-BMP9 binding (<xref rid="fig2" ref-type="fig">Figures 2</xref>A and 2B), norÂ does it have the ability to bind BMP9 itself (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S4</xref>E, laneÂ 11). Moreover, the OR1-BMP9 interaction is consistent with the observation that OR2âwhich appears to have some degree of flexibility relative to OR1 (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S4</xref>F)âdoes not bind BMP9 when expressed by itself (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S3</xref>B).<fig id="fig2"><label>FigureÂ 2</label><caption><p>A Hydrophobic Surface of ENG OR1 Binds to the Knuckle Region of BMP9</p><p>(A) Crystal structure of the OR-BMP9 complex, showing the dimer generated by crystal symmetry. OR is colored as in <xref rid="fig1" ref-type="fig">Figures 1</xref>B and 1C, and BMP9 chains are shown in yellow.</p><p>(B) Non-reducing immunoblot and Coomassie (CBB) analysis of His pull-down of <sup>M</sup>OR/BMP9 co-expression experiments. Two copies of OR bind dimeric BMP9 but do not interact with each other.</p><p>(C) Detail of the OR1-BMP9 interface, with the surface of OR1 colored by hydrophobicity (orange, most hydrophobic; white, least hydrophobic).</p><p>(D) Alternative view of (C), with both proteins in cartoon representation and interface residues shown in ball-and-stick representation.</p><p>(E) BMP9 is pulled down by non-mMBP fused wild-type OR but not by double or triple mutant ORs, indicating that the residues shown in (D) are essential for binding.</p><p>See also <xref rid="mmc1" ref-type="supplementary-material">Figures S4</xref> and <xref rid="mmc1" ref-type="supplementary-material">S8</xref> and <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>.</p></caption><graphic xlink:href="gr2"/></fig></p>
        <p>The structure of the complex reveals that the ENG-BMP9 interface is largely hydrophobic (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>C). It comprises OR1 residues that contribute to ENG strand Î²20 or immediately precede it (I271 and Q270 or N268, respectively; <xref rid="fig2" ref-type="fig">FigureÂ 2</xref>D; <xref rid="mmc1" ref-type="supplementary-material">FigureÂ S3</xref>A), which are close to BMP9 residues P412, T413, and Y416 (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>D). Consistent with a nanomolar binding affinity for BMP9 (<xref rid="tbl1" ref-type="table">Table 1</xref>; <xref rid="bib4" ref-type="bibr">Alt etÂ al., 2012</xref>, <xref rid="bib14" ref-type="bibr">Castonguay etÂ al., 2011</xref>, <xref rid="bib24" ref-type="bibr">Gregory etÂ al., 2014</xref>), individual mutations of ENG residues N268, Q270, and I271 are not sufficient to disrupt the interaction between unfused OR and BMP9 (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S4</xref>E, lanes 2, 4, and 5). However, double and triple combinations of these mutations show that OR1 residues Q270 and I271 (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>D; <xref rid="mmc1" ref-type="supplementary-material">FigureÂ S3</xref>A), which are highly conserved in mammals, are essential for BMP9 binding (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>E). Importantly, neither the aforementioned individual mutations nor their combinations affect OR folding because the corresponding proteins are secreted comparably with wild-type OR (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S4</xref>E, lanes 2, 4, 5, and 10; <xref rid="fig2" ref-type="fig">FigureÂ 2</xref>E). Similarly, alanine mutants of D246, Y277, and F290 are secreted normally, although, in this case, the mutant proteins are still able to bind BMP9 (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S4</xref>E, lanes 1, 6, and 9). In contrast, mutation of the buried hydrophobic residue M269 severely affects OR folding and secretion; however, the fraction of protein that is correctly folded and secreted retains BMP9-binding activity (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S4</xref>E, lane 3). Interestingly, 9 of 11 residues located in the BMP9 Î²6âÎ²7 region that contacts OR1 are conserved in BMP10, the other high-affinity ligand of ENG (<xref rid="bib14" ref-type="bibr">Castonguay etÂ al., 2011</xref>). On the contrary, these residues differ significantly in BMPs that either do not bind ENG or interact only weakly with it (<xref rid="bib14" ref-type="bibr">Castonguay etÂ al., 2011</xref>, <xref rid="bib24" ref-type="bibr">Gregory etÂ al., 2014</xref>; <xref rid="mmc1" ref-type="supplementary-material">FigureÂ S4</xref>G). Most importantly, the interface region of ENG also involves conserved S278 and invariant F282, whose mutation in HHT1 patients disrupts BMP9-dependent signaling (<xref rid="bib38" ref-type="bibr">Mallet etÂ al., 2015</xref>) as well as inÂ vitro binding between OR and BMP9 (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>E; <xref rid="mmc1" ref-type="supplementary-material">FigureÂ S4</xref>E, lanes 7 and 8). Further supporting the cell signaling studies (<xref rid="bib38" ref-type="bibr">Mallet etÂ al., 2015</xref>) and our pull-down experiments (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>E), quantitative analysis of protein-protein interaction by biolayer interferometry (BLI) shows that the mutations Q270A/I271A, S278P, and F282V completely abolish the binding of unfused OR to BMP9. Moreover, BLI confirms that mMBP fusion does not interfere with the interaction between wild-type OR and BMP9 (<xref rid="tbl1" ref-type="table">Table 1</xref>; <xref rid="mmc1" ref-type="supplementary-material">FigureÂ S8</xref>).<table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>Kinetics Analysis of ENG-BMP9 Interaction by BLI</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>K<sub>D</sub> (M)</th><th>k<sub>on</sub> (M<sup>â1</sup>s<sup>â1</sup>)</th><th>k<sub>off</sub> (s<sup>â1</sup>)</th></tr></thead><tbody><tr><td>ECTO</td><td>9.81Â Ã 10<sup>â9</sup></td><td align="char">2.0Â Ã 10<sup>5</sup> Â± 1.69Â Ã 10<sup>3</sup></td><td align="char">1.98Â Ã 10<sup>â3</sup> Â± 1.15Â Ã 10<sup>â5</sup></td></tr><tr><td>OR</td><td>2.95Â Ã 10<sup>â7</sup></td><td align="char">2.95Â Ã 10<sup>5</sup> Â± 8.96Â Ã 10<sup>3</sup></td><td align="char">8.71Â Ã 10<sup>â2</sup> Â± 9.08Â Ã 10<sup>â4</sup></td></tr><tr><td><sup>M</sup>OR</td><td>1.79Â Ã 10<sup>â7</sup></td><td align="char">3.49Â Ã 10<sup>5</sup> Â± 1.3Â Ã 10<sup>4</sup></td><td align="char">6.22Â Ã 10<sup>â2</sup> Â± 7.76Â Ã 10<sup>â4</sup></td></tr><tr><td>OR F282V</td><td>NBD</td><td/><td/></tr><tr><td>OR S278P</td><td>NBD</td><td/><td/></tr><tr><td>OR Q270A/I271A</td><td>NBD</td><td/><td/></tr><tr><td>mMBP</td><td>NBD</td><td/><td/></tr></tbody></table><table-wrap-foot><fn><p>NBD, no binding detected under the tested experimental conditions. See also <xref rid="mmc1" ref-type="supplementary-material">FigureÂ S8</xref>.</p></fn></table-wrap-foot></table-wrap></p>
        <p>Interestingly, the epitope of TRC105/SN6j, a monoclonal antibody to ENG used in clinical trials and acting as a tumor suppressor (<xref rid="bib52" ref-type="bibr">She and Seon, 2001</xref>, <xref rid="bib8" ref-type="bibr">Bernabeu etÂ al., 2009</xref>, <xref rid="bib43" ref-type="bibr">Nolan-Stevaux etÂ al., 2012</xref>, <xref rid="bib45" ref-type="bibr">Paauwe etÂ al., 2016</xref>), overlaps with the BMP9-binding region of OR1 (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>A, red). This explains why TRC105, but not SN6h, whose target epitope is elsewhere on ENG (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>A, cyan), inhibits BMP9-dependent signaling (<xref rid="bib43" ref-type="bibr">Nolan-StevauxÂ etÂ al., 2012</xref>). Similarly, overlap of the BMP9 binding siteÂ with the prodomain region of pro-BMP9 (<xref rid="bib40" ref-type="bibr">Mi etÂ al., 2015</xref>) (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S4</xref>H) explains why the prodomain is displaced upon interaction with ENG (<xref rid="bib31" ref-type="bibr">Kienast etÂ al., 2016</xref>).</p>
      </sec>
      <sec id="sec2.4">
        <title>The ZP Module of ENG Adopts a Minimal Fold with a Short ZP-N/ZP-C Linker</title>
        <p>Whereas the BMP9-binding activity of ENG depends on OR, the ZP moiety mediates its dimerization and spatial organization within the complex. Whereas an unfused ZP construct was barely secreted (<xref rid="bib10" ref-type="bibr">Bokhove etÂ al., 2016a</xref>), mMBP-fused ENG P338âG581 (<sup>M</sup>ZP; <xref rid="mmc1" ref-type="supplementary-material">FigureÂ S1</xref>B) could be efficiently expressed as a mixture of monomer and intermolecularly disulfide-bonded homodimer (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S5</xref>A, left). Although the relative ratio of the latter species significantly increased upon sample concentration (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S5</xref>A, right), crystallization selected the monomer (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S5</xref>B). The 2.7 Ã structure of <sup>M</sup>ZP displays the hallmarks of a typical ZP module composed of ZP-N and ZP-C domains with C<sub>1</sub>-C<sub>4</sub>, C<sub>2</sub>-C<sub>3</sub> and C<sub>5</sub>-C<sub>7</sub> disulfide connectivity, respectively (<xref rid="bib11" ref-type="bibr">Bokhove etÂ al., 2016b</xref>, <xref rid="bib26" ref-type="bibr">Han etÂ al., 2010</xref>, <xref rid="bib35" ref-type="bibr">Litscher and Wassarman, 2015</xref>; <xref rid="fig3" ref-type="fig">Figures 3</xref>A and <xref rid="fig4" ref-type="fig">4</xref>A; <xref rid="mmc1" ref-type="supplementary-material">Figures S5</xref>C, S5D, and <xref rid="mmc1" ref-type="supplementary-material">S6</xref>); however, it also contains several specific features. Consistent with a role of ENG in integrin-mediated cell adhesion (<xref rid="bib22" ref-type="bibr">Gougos and Letarte, 1990</xref>, <xref rid="bib50" ref-type="bibr">Rossi etÂ al., 2015</xref>), the RGD motif of the protein constitutes a short exposed loop of ZP-N (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>A, left). Moreover, following the disordered OR/ZP linker residues P338âD348, C350 before Î±A forms a disulfide with C382 located after Î±BC (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>A; <xref rid="mmc1" ref-type="supplementary-material">FigureÂ S5</xref>D). This is reminiscent of a comparable disulfide in uromodulin (UMOD), another ZP module-containing protein (<xref rid="bib11" ref-type="bibr">Bokhove etÂ al., 2016b</xref>). In agreement with an important structural role of this disulfide, loss of C382 is associated with HHT1 (<xref rid="bib53" ref-type="bibr">Stenson etÂ al., 2014</xref>; University of Utah Department of Pathology HHT and ENG Database, <ext-link ext-link-type="uri" xlink:href="http://www.arup.utah.edu/database/ENG/ENG_welcome.php" id="intref0015">http://www.arup.utah.edu/database/ENG/ENG_welcome.php</ext-link>), and mutation of C350 and/or C382 disrupts ENG folding and secretion (<xref rid="fig4" ref-type="fig">Figures 4</xref>B and 4C).<fig id="fig3"><label>FigureÂ 3</label><caption><p>ENG Contains a Minimal ZP Module with Closely Interacting ZP-N and ZP-C Domains</p><p>(A) Crystal structure of ENG ZP, colored according to secondary structure. Canonical disulfide bonds and the RGD motif are shown in ball-and-stick representation. The extra ZP-N disulfide (C350âC382) and the free ZP-C Cys involved in dimerization (C516) are also indicated.</p><p>(B) Side-by-side comparison of the ENG and UMOD ZP modules. The secondary structure elements of ENG ZP-N and ZP-C are only spaced by five residues; thus, these domains are much closer to each other than the corresponding domains of UMOD, which are separated by a long linker (red). As a result, whereas the ZP-N homodimerization surface of UMOD is available to pair with another molecule (black/gray), the equivalent region of ENG interacts with ZP-C and maintains the protein in a monomeric state.</p><p>See also <xref rid="mmc1" ref-type="supplementary-material">Figures S1</xref>, <xref rid="mmc1" ref-type="supplementary-material">S5</xref>, and <xref rid="mmc1" ref-type="supplementary-material">S6</xref> and <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>.</p></caption><graphic xlink:href="gr3"/></fig><fig id="fig4"><label>FigureÂ 4</label><caption><p>Intermolecular Disulfide Bonding of ENG ZP C516 Generates a Homodimeric Clamp for the BMP9 Ligand</p><p>(A) The disulfide bonds observed in the structures of OR (<xref rid="fig1" ref-type="fig">Figures 1</xref>A and 1B; <xref rid="mmc1" ref-type="supplementary-material">FigureÂ S2</xref>D) and ZP (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>A; <xref rid="mmc1" ref-type="supplementary-material">FigureÂ S5</xref>D) are indicated in red. Because neither ENG E26-S337 (<xref rid="bib14" ref-type="bibr">Castonguay etÂ al., 2011</xref>) nor <sup>M</sup>OR (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>B; <xref rid="mmc1" ref-type="supplementary-material">FigureÂ S1</xref>C) make intermolecular disulfide bonds, the pattern suggests that homodimerization of ENG is mediated by a C516-C516 disulfide in addition to C582-C582 (<xref rid="bib25" ref-type="bibr">Guerrero-Esteo etÂ al., 2002</xref>).</p><p>(B) A non-reducing anti-His immunoblot of conditioned medium (M) shows secretion of monomeric and dimeric ENG ZP constructs (white and black arrowheads, respectively). Immunoblot of cell lysates (L) indicates that all constructs are expressed in equal amounts. Consistent with the ENG architecture proposed in (A), mutation of C516 abolishes homodimerization of <sup>M</sup>ZP. Moreover, the additional C350âC382 disulfide found in ENG ZP-N (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>A; <xref rid="mmc1" ref-type="supplementary-material">FigureÂ S5</xref>D) is essential for <sup>M</sup>ZP secretion.</p><p>(C) Disulfide connectivity and secretion state of the <sup>M</sup>ZP constructs analyzed in (B). Lack of secretion is symbolized by a red cross.</p><p>(D) Immunoblot and Coomassie analyses of co-expression experiments under non-reducing conditions show that two ENGÂ molecules, preferentially a disulfide-bonded dimer, bind homodimeric BMP9.</p><p>(E) SEC-MALS analysis of purified His-ECTO-BMP9 complex produced in HEK293S cells reveals two conformations whose common molecular mass (red line) is consistent with a 2:2 stoichiometry.</p><p>(F) Theoretical model of the complete extracellular region of homodimeric ENG in complex with BMP9. The relative orientation of the ZP-C domains cross-linked by the C516-C516 intermolecular disulfide (dashed red ellipse) is compatible with the C582-C582 disulfide (<xref rid="bib25" ref-type="bibr">Guerrero-Esteo etÂ al., 2002</xref>) at the CÂ terminus of the ectodomain (dashed black ellipse).</p><p>See also <xref rid="mmc1" ref-type="supplementary-material">Figures S1</xref> and <xref rid="mmc1" ref-type="supplementary-material">S6</xref>.</p></caption><graphic xlink:href="gr4"/></fig></p>
        <p>Although the structure of ZP does not support a role for C350 in ENG dimerization (<xref rid="bib4" ref-type="bibr">Alt etÂ al., 2012</xref>), Cys mutagenesis reveals that, in addition to a C582-C582 disulfide (<xref rid="bib25" ref-type="bibr">Guerrero-Esteo etÂ al., 2002</xref>), dimerization involves C516 (<xref rid="fig4" ref-type="fig">Figures 4</xref>Aâ4C). This agrees with the observation that, in the monomeric ZP structure, C516 is exposed on the surface of ZP-C (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>A). By consisting of only 133 residues and containing a single intramolecular disulfide bond, the latter represents a simplified version of the ZP-C domain found in other ZP modules proteins (<xref rid="bib11" ref-type="bibr">Bokhove etÂ al., 2016b</xref>, <xref rid="bib26" ref-type="bibr">Han etÂ al., 2010</xref>) (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>B), including closely related betaglycan (BG)/TGF-Î² receptor III (<xref rid="bib8" ref-type="bibr">Bernabeu etÂ al., 2009</xref>, <xref rid="bib18" ref-type="bibr">Diestel etÂ al., 2013</xref>, <xref rid="bib34" ref-type="bibr">Lin etÂ al., 2011</xref>) (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S6</xref>).</p>
        <p>In the ZP module of ENG, a minimal interdomain linker forces a 3<sub>10</sub> helix within the FG loop of ZP-C to pack against the Î²A-Î²G surface of ZP-N; remarkably, the corresponding surface of UMOD mediates ZP-N/ZP-N homodimerization and is essential for protein polymerization (<xref rid="bib11" ref-type="bibr">Bokhove etÂ al., 2016b</xref>) (<xref rid="fig3" ref-type="fig">Figures 3</xref>A and 3B). Taken together, these observations support the idea that, in addition to the lack of a consensus cleavage site within the FG loop of ZP-C (<xref rid="bib34" ref-type="bibr">Lin etÂ al., 2011</xref>), close spacing of the ZP-N and ZP-C domains of ENG and BG (which also contains a helix within its ZP-C FG loop; <xref rid="mmc1" ref-type="supplementary-material">FigureÂ S6</xref>; <xref rid="bib34" ref-type="bibr">Lin etÂ al., 2011</xref>) underlies their inability to polymerize like other ZP module proteins (<xref rid="bib11" ref-type="bibr">Bokhove etÂ al., 2016b</xref>) (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>B).</p>
      </sec>
      <sec id="sec2.5">
        <title>ZP-Mediated Dimerization of ENG Clamps BMP9 within the Signaling Complex</title>
        <p>To investigate the solution stoichiometry of the ENG-BMP9 complex, we co-expressed His-<sup>M</sup>ECTO (â¼120Â kDa), ECTO-Myc (â¼80Â kDa), and BMP9 (2Â Ã 12.1Â kDa) (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>D). This generates five distinct species, shown in colored boxes: His-<sup>M</sup>ECTO homodimer (â¼240Â kDa, blue), His-<sup>M</sup>ECTO/ECTO-Myc heterodimer (â¼200Â kDa, green), ECTO-Myc homodimer (â¼160Â kDa, red), His-<sup>M</sup>ECTO monomer (cyan), and ECTO-Myc monomer (magenta). His pull-down followed by anti-Myc immunoblot detects disulfide-bonded His-<sup>M</sup>ECTO/ECTO-Myc heterodimers bound to BMP9 (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>D, lane 1). Because no monomeric ECTO-Myc is present in lane 1, BMP9 is preferentially bound by disulfide-bonded dimeric ENG. Furthermore, the same lane shows lack of homodimeric ECTO-Myc among the material pulled down by immobilized metal affinity chromatography (IMAC), excluding that BMP9 binds more than one ENG dimer or higher oligomeric forms of the protein. Analysis of a purified ECTO-BMP9 complex by size exclusion chromatography with multi-angle light scattering (SEC-MALS) confirmed these results by detecting a molecular mass of â¼150Â kDa (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>E).</p>
        <p>Based on the combination of our crystallographic and biochemical data (<xref rid="fig1" ref-type="fig">Figures 1</xref>, <xref rid="fig2" ref-type="fig">2</xref>, <xref rid="fig3" ref-type="fig">3</xref>, and <xref rid="fig4" ref-type="fig">4</xref>Aâ4E), we have modeled the BMP9-bound state of homodimeric ENG (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>F). As a result of the intermolecular cross-linking provided by ZP disulfide C516-C516 (<xref rid="fig4" ref-type="fig">Figures 4</xref>B and 4C) as well as membrane-proximal C582-C582 (<xref rid="bib25" ref-type="bibr">Guerrero-Esteo etÂ al., 2002</xref>), the two ENG molecules generate a clamp-like structure whose OR arms protrude into the extracellular space to secure the knuckles of the BMP9 homodimer. Consistent with this proposed architecture, which is compatible with MMP-14 cleavage of ENG at G586|L587 (<xref rid="bib27" ref-type="bibr">Hawinkels etÂ al., 2010</xref>), pull-down experiments suggest that ENG ZP does not interact directly with BMP9 (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S5</xref>E). However, the ZP must indirectly lower the dissociation of BMP9 from OR, because, as previously observed by surface plasmon resonance (SPR) using an OR construct truncated at P338 (<xref rid="bib4" ref-type="bibr">Alt etÂ al., 2012</xref>), the dissociation rate constant (k<sub>off</sub>) of the OR-BMP9 complex is significantly higher than that of ECTO-BMP9 (<xref rid="tbl1" ref-type="table">Table 1</xref>). Together with the structure and SEC-MALS-derived stoichiometry (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>E), this observation suggests that, by covalently cross-linking two protein chains (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>B), ZP confers an antibody-like architecture to ENG. This has the effect of increasing the avidity of the ENG-BMP9 interaction by presenting two closely spaced OR1 binding sites that both match the homodimeric structure of the ligand and counteract its dissociation from a single OR1 site (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>F). Consistent with this idea, longer OR constructs that are non-physiologically cross-linked into dimers by pairs of C350 (which normally makes an intramolecular disulfide with C382; <xref rid="fig3" ref-type="fig">FigureÂ 3</xref>A; <xref rid="mmc1" ref-type="supplementary-material">FigureÂ S5</xref>D) dissociate much slower from BMP9 than monomeric OR (<xref rid="bib4" ref-type="bibr">Alt etÂ al., 2012</xref>, <xref rid="bib14" ref-type="bibr">Castonguay etÂ al., 2011</xref>).</p>
        <p>Taken together, these considerations suggest that ZP not only provides a structural scaffold that spaces OR from the plasma membrane, positioning BMP9 for interaction with type I and II receptors such as ALK1 and ActRIIB, but also affects signaling by indirectly increasing ligand retention.</p>
      </sec>
      <sec id="sec2.6">
        <title>The ENG-BMP9 Interface Is Compatible with Binding of ALK1, but not ActRIIB, to BMP9</title>
        <p>BMP9-dependent signaling in endothelial cells is thought to be regulated by the association of the ligand with ENG and the type I receptor ALK1 (<xref rid="bib51" ref-type="bibr">Scharpfenecker etÂ al., 2007</xref>). By merging the model of ENG-BMP9 (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>F) with the structure of ALK1-BMP9 in crystals of ALK1-BMP9-ActRIIB (<xref rid="bib54" ref-type="bibr">Townson etÂ al., 2012</xref>), the extracellular part of an ENG-BMP9-ALK1 ternary complex can be straightforwardly modeled (<xref rid="fig5" ref-type="fig">Figures 5</xref>A and 5B). The resulting assembly suggests that, whereas ALK1 binds to theÂ wrist of BMP9 (<xref rid="bib54" ref-type="bibr">Townson etÂ al., 2012</xref>), the knuckle region of the ligand is recognized non-competitively by ENG OR1 (<xref rid="fig2" ref-type="fig">Figures 2</xref>Aâ2D). Also considering that ENG and ALK1 are physically spaced from each other by the finger/knuckle region of the ligand (<xref rid="fig5" ref-type="fig">FigureÂ 5</xref>A), this agrees with SPR binding studies suggesting that ENG and ALK1 bind independently and non-cooperatively to BMP9 (<xref rid="bib4" ref-type="bibr">Alt etÂ al., 2012</xref>, <xref rid="bib14" ref-type="bibr">Castonguay etÂ al., 2011</xref>). Accordingly, a soluble triple complex could be detected upon co-expression of BMP9, ECTO, and the extracellular part of ALK1 (<xref rid="fig5" ref-type="fig">FigureÂ 5</xref>C). On the other hand, comparison of the ternary complex model (<xref rid="fig5" ref-type="fig">FigureÂ 5</xref>B) with the structure of ALK1-BMP9-ActRIIB (<xref rid="bib54" ref-type="bibr">Townson etÂ al., 2012</xref>; <xref rid="fig5" ref-type="fig">FigureÂ 5</xref>D) indicates that OR1 and the type II receptor ActRIIB compete for the same region of BMP9. This is consistent with SPR-based evidence that ENG and ActRIIB bind to BMP9 in a mutually exclusive way (<xref rid="bib14" ref-type="bibr">Castonguay etÂ al., 2011</xref>) and likely also applies to BMPRII because previous structural studies showed that type II receptors always interact with the knuckle region of growth factors (<xref rid="bib28" ref-type="bibr">Hinck etÂ al., 2016</xref>).<fig id="fig5"><label>FigureÂ 5</label><caption><p>Theoretical Model of the ENG-BMP9-ALK1 Ternary Complex</p><p>(A) Combination of the homodimeric ENG-BMP9 model shown in <xref rid="fig4" ref-type="fig">FigureÂ 4</xref>F with structural information on how the type I receptor ALK1 binds BMP9 (<xref rid="bib54" ref-type="bibr">Townson etÂ al., 2012</xref>) suggests a possible architecture for the co-receptor-BMP ligand-typeÂ I receptor ternary complex on the plasma membrane.</p><p>(B) Top view of the ENG-BMP9-ALK1 model.</p><p>(C) SDS-PAGE analysis of ENG ECTO-FLAG, ALK1-His, and BMP9 co-expression followed by His pull-down confirms that the proteins form a triple complex in solution. Consistent with the model depicted in (A) and (B), ALK1 is only able to pull down ECTO when BMP9 is present. All samples were analyzed under non-reducing conditions, except for that marked with RÂ (reducing conditions).</p><p>(D) Top view of the crystal structure of the ALK1-BMP9-ActRIIB complex (<xref rid="bib54" ref-type="bibr">Townson etÂ al., 2012</xref>). Comparison with the ENG-BMP9-ALK1 model (B) suggests that ENG and ActRIIB compete for the same binding region on BMP9.</p></caption><graphic xlink:href="gr5"/></fig></p>
        <p>Together with the observation that ENG binds BMP9 with comparable affinity to ALK1 (<xref rid="bib4" ref-type="bibr">Alt etÂ al., 2012</xref>) but is significantly more abundant than the type I receptor in endothelial cells (<xref rid="bib2" ref-type="bibr">Abdalla etÂ al., 2000</xref>, <xref rid="bib16" ref-type="bibr">Cheifetz etÂ al., 1992</xref>, <xref rid="bib44" ref-type="bibr">Ohta etÂ al., 1987</xref>, <xref rid="bib48" ref-type="bibr">Quackenbush and Letarte, 1985</xref>), these findings support a model where homodimeric BMP9 is first efficiently captured and retained on the surface of endothelial cells by the bivalent architecture of ENG, and a ternary complex is then formed upon non-competitive recruitment of ALK1 (<xref rid="fig5" ref-type="fig">Figures 5</xref>Aâ5C). Presentation of the ligand to a type II receptor, a step requiring BMP9 release from its binding site on ENG, would finally initiate signal transduction. Mirroring the case of antagonistic TGF-Î² family ligands (<xref rid="bib6" ref-type="bibr">Aykul and Martinez-Hackert, 2016</xref>), this model would corroborate the idea that different receptors can compete for the same ligand to modulate signaling (<xref rid="bib37" ref-type="bibr">Mahlawat etÂ al., 2012</xref>). Although it remains to be established how captured BMP9 becomes available to ActRIIB/BMPRII, the fact that the ligand has a relatively high k<sub>off</sub> for a single OR1 site (<xref rid="tbl1" ref-type="table">Table 1</xref>) suggests that this interaction may be triggered by transient dissociation of homodimeric BMP9 from one of its two binding sites on ENG. This would temporarily free one of the knuckle regions of BMP9 for recognition by a type II receptor located close to the ternary ENG-BMP9-ALK1 complex on the plasma membrane. Considering that ActRIIB has a lower k<sub>off</sub> than OR (<xref rid="tbl1" ref-type="table">Table 1</xref>; <xref rid="bib4" ref-type="bibr">Alt etÂ al., 2012</xref>, <xref rid="bib6" ref-type="bibr">Aykul and Martinez-Hackert, 2016</xref>, <xref rid="bib54" ref-type="bibr">Townson etÂ al., 2012</xref>), subsequent dissociation of the second knuckle of BMP9 from ENG would effectively result in transfer of the ALK1-bound ligand to the type II receptor. Elucidation of the details of the signal transduction mechanism will require further structural studies of the intact ternary complex. This may adopt a range of conformations not recapitulated by our crystal structure-based model as a result of flexibility at the ENG OR/ZP junctionâpossibly underlying the two ECTO-BMP9 states observed by SEC-MALS (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>E)âas well as membrane anchoring.</p>
      </sec>
      <sec id="sec2.7">
        <title>Structural Basis of HHT1</title>
        <p>Mapping of almost 100 gene variants linked to HHT1 (<xref rid="bib38" ref-type="bibr">Mallet etÂ al., 2015</xref>, <xref rid="bib46" ref-type="bibr">Paquet etÂ al., 2001</xref>, <xref rid="bib53" ref-type="bibr">Stenson etÂ al., 2014</xref>; University of Utah Department of Pathology HHT and ENG database, <ext-link ext-link-type="uri" xlink:href="http://www.arup.utah.edu/database/ENG/ENG_welcome.php" id="intref0020">http://www.arup.utah.edu/database/ENG/ENG_welcome.php</ext-link>) onto the structure of ENG indicates that, with the exception of previously discussed OR1 residues S278 and F282 (<xref rid="fig2" ref-type="fig">Figures 2</xref>D and 2E), the majority of HHT1 missense mutations affect buried hydrophobic residues (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S7</xref>).</p>
        <p>Fifteen representative mutation sites, ten in OR and five inÂ ZP, are highlighted in <xref rid="fig6" ref-type="fig">Figures 6</xref>A and 6B, respectively. The structure of ENG reveals that mutations L32R/H, G52D/V, L82H, V125D, L162R, L170P, L221P, I252T, L262P, I384T, and S407Q/N interfere with hydrophobic core packing, explaining the impaired expression and/or secretion of the corresponding mutants (<xref rid="bib3" ref-type="bibr">Ali etÂ al., 2011</xref>, <xref rid="bib38" ref-type="bibr">Mallet etÂ al., 2015</xref>, <xref rid="bib46" ref-type="bibr">Paquet etÂ al., 2001</xref>, <xref rid="bib47" ref-type="bibr">Pece-Barbara etÂ al., 1999</xref>). The same phenotype is also caused by mutations C53R, C207R, C363Y, C382W/G, C412Y/S, C493Y, and R529C, whichâas observed in the case of the mutant C382S (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>B)âdisrupt folding by interfering with correct disulfide bond formation (<xref rid="mmc1" ref-type="supplementary-material">Figures S2</xref>D and <xref rid="mmc1" ref-type="supplementary-material">S5</xref>D; <xref rid="bib3" ref-type="bibr">Ali etÂ al., 2011</xref>, <xref rid="bib38" ref-type="bibr">Mallet etÂ al., 2015</xref>, <xref rid="bib46" ref-type="bibr">Paquet etÂ al., 2001</xref>, <xref rid="bib47" ref-type="bibr">Pece-Barbara etÂ al., 1999</xref>). The two effects are combined in the case of the mutation W149C, which severely impairs trafficking of ENG to the cell surface (<xref rid="bib3" ref-type="bibr">Ali etÂ al., 2011</xref>, <xref rid="bib47" ref-type="bibr">Pece-Barbara etÂ al., 1999</xref>) by replacing a largely buried hydrophobic side chain (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>A) with a reactive residue that could introduce a spurious disulfide bond. Finally, ENG secretion is also affected by mutations such as D391Y and R437W (<xref rid="bib3" ref-type="bibr">Ali etÂ al., 2011</xref>, <xref rid="bib38" ref-type="bibr">Mallet etÂ al., 2015</xref>), which substitute solvent-exposed residues (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>B) with hydrophobic amino acids.<fig id="fig6"><label>FigureÂ 6</label><caption><p>HHT1-Associated Mutations Disrupt the Folding of ENG</p><p>(A and B) Overview and close-ups of ENG OR (A) and ZP (B), with patient mutation sites highlighted in magenta. Disulfide bonds and C516 are shown in ball-and-stick representation; coloring is according to <xref rid="fig2" ref-type="fig">Figures 2</xref> and <xref rid="fig3" ref-type="fig">3</xref>. Relative percentages of solvent accessibilities of residue side chains are indicated in parenthesis. See also <xref rid="mmc1" ref-type="supplementary-material">FigureÂ S7</xref>.</p></caption><graphic xlink:href="gr6"/></fig></p>
        <p>In summary, analysis of the ENG structure suggests that most HHT1 mutations impair its folding rather than directly hinderÂ its ability to engage in protein-protein interactions. This leads to reduced amount of functional ENG at the cell surface, thereby causing HHT1 by haploinsufficiency (<xref rid="bib46" ref-type="bibr">Paquet etÂ al., 2001</xref>).</p>
      </sec>
      <sec id="sec2.8">
        <title>Conclusions</title>
        <p>By suggesting how the bivalent architecture of ENG secures a pool of BMP9 molecules on the plasma membrane, where they can bind to type I receptor ALK1 and become transiently available for interaction with the type II receptors ActRIIB and BMPRII, our studies shed light on some of the mechanisms underlying BMP pathway regulation. At the same time, structural knowledge of human ENG and its interaction with BMP9 constitutes a valuable framework for understanding the molecular basis of HHT. This disease is caused primarily (&gt;85%) by mutations in ENG (HHT1; <xref rid="bib30" ref-type="bibr">Johnson etÂ al., 1996</xref>, <xref rid="bib39" ref-type="bibr">McAllister etÂ al., 1994</xref>) and ALK1 (HHT2; <xref rid="bib30" ref-type="bibr">Johnson etÂ al., 1996</xref>, <xref rid="bib39" ref-type="bibr">McAllister etÂ al., 1994</xref>), but also by mutations in the common downstream signaling SMAD4 (<xref rid="bib19" ref-type="bibr">Gallione etÂ al., 2004</xref>) as well as in BMP9 itself in a very similar vascular anomaly syndrome (<xref rid="bib58" ref-type="bibr">Wooderchak-Donahue etÂ al., 2013</xref>). Our findings also contribute to clarifying the tumor-suppressing activity of monoclonal TRC105, which targets the ENG-BMP9 interface (<xref rid="bib43" ref-type="bibr">Nolan-Stevaux etÂ al., 2012</xref>). Future studies are needed to understand how ENG forms complexes with other ligands of the TGF-Î² superfamily, for which it has much lower affinities than for BMP9, and to elucidate how ENG contributes to type II receptor-mediated signaling.</p>
      </sec>
    </sec>
    <sec id="sec3">
      <title>Experimental Procedures</title>
      <sec id="sec3.1">
        <title>DNA Constructs</title>
        <p>For secreted expression of unfused proteins, cDNA fragments including tag-encoding sequences were cloned into mammalian expression vector pHLsec (<xref rid="bib5" ref-type="bibr">Aricescu etÂ al., 2006</xref>). Except in the case of ECTO and OR constructs, which were expressed using the native signal peptide of ENG (residues M1âA25), ENG inserts were cloned in-frame with the CrypÎ± signal peptide-encoding sequence of pHLsec. Constructs encoding non-mMBP-fused, C-terminally 8His-tagged OR1 with its native signal peptide (ENG M1-T46-(GGGS)<sub>2</sub>-L203-S329-C242S) and extracellular C-terminally 6His-tagged ALK1 (residues D22âG114) with its native signal peptide (residues M1âG21) were synthesized (DNA2.0/ATUM) and cloned into pHLsec. mMBP fusion proteins were expressed using pHLmMBP vectors (<xref rid="bib10" ref-type="bibr">Bokhove etÂ al., 2016a</xref>), which are available at Addgene (<ext-link ext-link-type="uri" xlink:href="https://www.addgene.org/Luca_Jovine/" id="intref0025">https://www.addgene.org/Luca_Jovine/</ext-link>). C-terminally FLAG-tagged ECTO was expressed using a previously described pCMV5 vector (<xref rid="bib23" ref-type="bibr">Gregory, 2011</xref>). The cDNA encoding residues M1âR429 of human BMP9 was cloned into pHLsec without any tags so that purification of mature BMP9 depended on its ability to form a complex with His-tagged ENG partners.</p>
        <p>Mutations were generated by overlap extension PCR, and all constructs were verified by DNA sequencing (Eurofins Genomics).</p>
      </sec>
      <sec id="sec3.2">
        <title>Protein Expression</title>
        <p>Large-scale production of <sup>M</sup>OR and the <sup>M</sup>OR-BMP9 complex for crystallographic studies was performed in HEK293S cells expressing EndoglycosidaseÂ H (Endo H)-sensitive, high mannose-type glycoproteins (<xref rid="bib15" ref-type="bibr">Chang etÂ al., 2007</xref>, <xref rid="bib49" ref-type="bibr">Reeves etÂ al., 2002</xref>). HEK293S cells were grown in Dulbecco's modified Eagle's medium (DMEM) with 4Â mM L-glutamine (Life Technologies/Thermo Fisher Scientific) and 10% (v/v) fetal bovine serum (Saveen &amp; Werner) at 37Â°C, 5% CO<sub>2</sub> using T flasks (150Â cm<sup>2</sup>, BD Biosciences) or cell factories (2,528Â cm<sup>2</sup>, Thermo Fisher Scientific). Transient transfections were essentially performed as described previously (<xref rid="bib5" ref-type="bibr">Aricescu etÂ al., 2006</xref>, <xref rid="bib10" ref-type="bibr">Bokhove etÂ al., 2016a</xref>). <sup>M</sup>OR-BMP9 and ECTO-BMP9 co-transfections were performed using a 3:7 DNA mass ratio of <sup>M</sup>OR versus BMP9. Because <sup>M</sup>ZP does not contain N-glycosylation sites, it was expressed in HEK293T cells.</p>
        <p>For functional assays, complexes were obtained by co-expression of His-<sup>M</sup>OR, Myc-<sup>M</sup>OR, and BMP9 in HEK293T cells using a 2.5:2.5:5 DNA ratio. His-<sup>M</sup>ECTO, ECTO-Myc, and BMP9 complexes were prepared using a 2:3:5 DNA ratio.</p>
      </sec>
      <sec id="sec3.3">
        <title>Protein Purification</title>
        <p>Three days post-transfection, conditioned medium containing secreted proteins was harvested, 0.22 Î¼m-filtered (Sarstedt), and adjusted to 20Â mM sodiumÂ 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonate (Na-HEPES) (pHÂ 7.8), 150Â mM NaCl, 5Â mM imidazole (IMAC binding buffer). 10Â mL nickel-nitrilotriacetic acid (Ni-NTA) agarose slurry (QIAGEN) was added per liter of medium and incubated overnight at 4Â°C on an overhead shaker (Heidolph). IMAC beads were then collected in a column, washed with binding buffer, and batch-eluted with a binding buffer containing 500Â mM imidazole. TheÂ eluted material was concentrated using a spin filter (Millipore) with an appropriate molecular weight cutoff. Concentrated protein was subjected to SEC directly after IMAC (HEK293T-produced <sup>M</sup>ZP) or after deglycosylation (HEK293S-produced <sup>M</sup>OR or <sup>M</sup>OR-BMP9 complex). Endo H deglycosylation of <sup>M</sup>OR and <sup>M</sup>OR-BMP9 was performed for 1Â hr at 37Â°C in 120Â mM sodium-potassium phosphate (pH 6.0) using a 1:10 mass ratio of enzyme to substrate. Concentrated proteins were applied to a Superdex 200 26/60 SEC column connected to an ÃKTAFPLC system (GE Healthcare). The composition of theÂ SEC running buffer was 20Â mM Na-HEPES (pH 7.8), 100Â mM NaCl, andÂ 1.5Â mM D-maltose for <sup>M</sup>OR; 500Â mM and 200Â mM NaCl were used for the <sup>M</sup>OR-BMP9 complex and <sup>M</sup>ZP, respectively. Protein-containing fractions were pooled, concentrated, and used for crystallization trials.</p>
        <p>For functional assays, media were harvested from HEK293T cells transfected in 150Â cm<sup>2</sup> T flasks (Sarstedt). Small-scale IMAC or IMAC/SEC pull-downs were performed using the same protocol as above, linearly scaled down. Following pull-down, IMAC beads with bound ENG or <sup>M</sup>ZP constructs were incubated with medium of HEK293T cells expressing BMP9 (consecutive pull-downs). Media obtained from His-<sup>M</sup>OR, Myc-<sup>M</sup>OR, and BMP9 co-expression were purified using IMAC and SEC, whereas media obtained from His-<sup>M</sup>ECTO, ECTO-Myc, <sup>M</sup>ZP, ZP, and BMP9 co-expression or ALK1-His, ECTO-FLAG, and BMP9 co-expression were purified by IMAC. In parallel, we established that mMBP does not pull down BMP9 (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S4</xref>E, lane 11).</p>
      </sec>
      <sec id="sec3.4">
        <title>Protein Analysis</title>
        <p>Cell lysates were prepared by resuspending cells from a 10 cm<sup>2</sup> culture well in lysis buffer (50Â mM Tris-HCl/50Â mM 3-(N-Morpholino)propanesulfonic acid [MOPS] [pH 7.7], 0.1% SDS, and 1Â mM EDTA) supplied with protease inhibitors (Roche) and benzonase (New England Biolabs), followed by 30Â min incubation at 4Â°C and filtration with a 0.22 Î¼m spin filter (Millipore). Conditioned medium was centrifuged for 5Â min at 500Â Ã <italic>g</italic>, and the cell pellet was discarded. The supernatant was filtered using a 0.22 Î¼m syringe filter or centrifuged at 4Â°C at 18,000Â Ã <italic>g</italic> for 15Â min.</p>
        <p>Proteins separated by SDS-PAGE were detected with SimplyBlue SafeStain (Invitrogen/Thermo Fisher Scientific) or transferred to nitrocellulose membranes (GE Healthcare) for immunoblotting with PentaÂ·His mouse monoclonal antibody (1:1,000, QIAGEN) or 9E10 anti-Myc mouse monoclonal antibody (1:2,000, Sigma-Aldrich). Chemiluminescence detection was performed with Western Lightning ECL Plus (PerkinElmer).</p>
      </sec>
      <sec id="sec3.5">
        <title>Protein-Protein Interactions</title>
        <p>Experimental details for BLI measurements and SEC-MALS analysis of the ENG-BMP9 interaction are reported in the <xref rid="mmc1" ref-type="supplementary-material">Supplemental Experimental Procedures</xref>.</p>
      </sec>
      <sec id="sec3.6">
        <title>Protein Crystallization</title>
        <p>Crystallization experiments were carried out by hanging drop vapor diffusion at room temperature using a mosquito crystallization robot (TTP Labtech). Droplet-shaped crystals of C-terminally 6His-tagged <sup>M</sup>OR (6Â mg/mL) were obtained in 0.1Â M Tris-HCl (pH 8.5) and 30% (w/v) PEG1000 (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S2</xref>A) and directly flash-cooled in liquid nitrogen for data collection. Because of the pH sensitivity of the ENG-BMP9 interaction, BMP9 crystals fortuitously appeared in drops set up with the <sup>M</sup>OR-BMP9 complex (11Â mg/mL) and a mother liquor consisting of 1.0Â M LiCl, 4% (w/v) PEG6000, and 0.1Â M Na-citrate (pH 3.5). For cryocooling, BMP9 crystals were adjusted to 1.0Â M LiCl, 6% (w/v) PEG6000, 0.1Â M Na-citrate (pH 4.0), and 30% (v/v) glycerol. Hexagonal bipyramidal crystals of N-terminally 6His-tagged <sup>M</sup>OR in complex with BMP9 (<sup>M</sup>OR-BMP9, 6Â mg/mL) grew in 1.1Â M ammonium tartrate (pH 7.0) and 25% saturated sucrose (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S4</xref>A). For data collection, crystals were directly flash-cooled in liquid nitrogen. Rod-shaped crystals of <sup>M</sup>ZP (9Â mg/mL) were obtained using 11.5% (v/v) 2-Methyl-2,4-pentanediol (MPD), 11.5% (w/v) PEG1000 and 11.5% (w/v) PEG3350, and 100Â mM 2-(N-Morpholino)ethanesulfonic acid (MES)/imidazole (pH 6.5) (<xref rid="mmc1" ref-type="supplementary-material">FigureÂ S5</xref>B). Before flash-cooling in liquid nitrogen, crystals were stabilized using a 50% (v/v) precipitant mix containing 10% (v/v) glycerol.</p>
      </sec>
      <sec id="sec3.7">
        <title>X-Ray Diffraction Data Collection and Structure Determination</title>
        <p>Experimental details for data collection, structure determination, as well as sequence and structure analysis are described in the <xref rid="mmc1" ref-type="supplementary-material">Supplemental Experimental Procedures</xref>. Data collection, refinement, and validation statistics are summarized in <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>.</p>
      </sec>
    </sec>
    <sec id="sec4">
      <title>Author Contributions</title>
      <p>T.S., M.B., R.C., S.Z.C., and L.H. expressed proteins and performed biological assays. T.S. and M.B. crystallized proteins. T.S., M.B., L.J., and D.d.S. collected crystallographic data. M.B. and L.J. determined and analyzed structures. T.S., M.B., R.C., S.Z.C., M.L., and L.J. wrote the manuscript.</p>
    </sec>
  </body>
  <back>
    <ref-list id="cebib0010">
      <title>References</title>
      <ref id="bib1">
        <element-citation publication-type="journal" id="sref1">
          <person-group person-group-type="author">
            <name>
              <surname>Abdalla</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Letarte</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease</article-title>
          <source>J.Â Med. Genet.</source>
          <volume>43</volume>
          <year>2006</year>
          <fpage>97</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">15879500</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <element-citation publication-type="journal" id="sref2">
          <person-group person-group-type="author">
            <name>
              <surname>Abdalla</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Pece-Barbara</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Vera</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tapia</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Paez</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Bernabeu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Letarte</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2</article-title>
          <source>Hum. Mol. Genet.</source>
          <volume>9</volume>
          <year>2000</year>
          <fpage>1227</fpage>
          <lpage>1237</lpage>
          <pub-id pub-id-type="pmid">10767348</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <element-citation publication-type="journal" id="sref3">
          <person-group person-group-type="author">
            <name>
              <surname>Ali</surname>
              <given-names>B.R.</given-names>
            </name>
            <name>
              <surname>Ben-Rebeh</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>John</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Akawi</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Milhem</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Al-Shehhi</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Al-Ameri</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Al-Shamisi</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Al-Gazali</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Endoplasmic reticulum quality control is involved in the mechanism of endoglin-mediated hereditary haemorrhagic telangiectasia</article-title>
          <source>PLoS ONE</source>
          <volume>6</volume>
          <year>2011</year>
          <fpage>e26206</fpage>
          <pub-id pub-id-type="pmid">22022569</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <element-citation publication-type="journal" id="sref4">
          <person-group person-group-type="author">
            <name>
              <surname>Alt</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Miguel-Romero</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Donderis</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Aristorena</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Blanco</surname>
              <given-names>F.J.</given-names>
            </name>
            <name>
              <surname>Round</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Rubio</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Bernabeu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Marina</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Structural and functional insights into endoglin ligand recognition and binding</article-title>
          <source>PLoS ONE</source>
          <volume>7</volume>
          <year>2012</year>
          <fpage>e29948</fpage>
          <pub-id pub-id-type="pmid">22347366</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <element-citation publication-type="journal" id="sref5">
          <person-group person-group-type="author">
            <name>
              <surname>Aricescu</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>E.Y.</given-names>
            </name>
          </person-group>
          <article-title>A time- and cost-efficient system for high-level protein production in mammalian cells</article-title>
          <source>Acta Crystallogr. D Biol. Crystallogr.</source>
          <volume>62</volume>
          <year>2006</year>
          <fpage>1243</fpage>
          <lpage>1250</lpage>
          <pub-id pub-id-type="pmid">17001101</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <element-citation publication-type="journal" id="sref6">
          <person-group person-group-type="author">
            <name>
              <surname>Aykul</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Martinez-Hackert</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Transforming Growth Factor-Î² family ligands can function as antagonists by competing for type II receptor binding</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>291</volume>
          <year>2016</year>
          <fpage>10792</fpage>
          <lpage>10804</lpage>
          <pub-id pub-id-type="pmid">26961869</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <element-citation publication-type="journal" id="sref7">
          <person-group person-group-type="author">
            <name>
              <surname>BellÃ³n</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>CorbÃ­</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lastres</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>CalÃ©s</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>CebriÃ¡n</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Vera</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cheifetz</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Massague</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Letarte</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>BernabÃ©u</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Identification and expression of two forms of the human transforming growth factor-Î²-binding protein endoglin with distinct cytoplasmic regions</article-title>
          <source>Eur. J. Immunol.</source>
          <volume>23</volume>
          <year>1993</year>
          <fpage>2340</fpage>
          <lpage>2345</lpage>
          <pub-id pub-id-type="pmid">8370410</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <element-citation publication-type="journal" id="sref8">
          <person-group person-group-type="author">
            <name>
              <surname>Bernabeu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Lopez-Novoa</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Quintanilla</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>The emerging role of TGF-Î² superfamily coreceptors in cancer</article-title>
          <source>Biochim. Biophys. Acta</source>
          <volume>1792</volume>
          <year>2009</year>
          <fpage>954</fpage>
          <lpage>973</lpage>
          <pub-id pub-id-type="pmid">19607914</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <element-citation publication-type="journal" id="sref9">
          <person-group person-group-type="author">
            <name>
              <surname>Bidart</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ricard</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Levet</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Samson</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mallet</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>David</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Subileau</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tillet</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Feige</surname>
              <given-names>J.-J.</given-names>
            </name>
            <name>
              <surname>Bailly</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain</article-title>
          <source>Cell. Mol. Life Sci.</source>
          <volume>69</volume>
          <year>2012</year>
          <fpage>313</fpage>
          <lpage>324</lpage>
          <pub-id pub-id-type="pmid">21710321</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <element-citation publication-type="journal" id="sref10">
          <person-group person-group-type="author">
            <name>
              <surname>Bokhove</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sadat Al Hosseini</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Dioguardi</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Gegenschatz-Schmid</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Nishimura</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Raj</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>de Sanctis</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Jovine</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Easy mammalian expression and crystallography of maltose-binding protein-fused human proteins</article-title>
          <source>J.Â Struct. Biol.</source>
          <volume>194</volume>
          <year>2016</year>
          <fpage>1</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">26850170</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <element-citation publication-type="journal" id="sref11">
          <person-group person-group-type="author">
            <name>
              <surname>Bokhove</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nishimura</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Brunati</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>de Sanctis</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Rampoldi</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Jovine</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>A structured interdomain linker directs self-polymerization of human uromodulin</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>113</volume>
          <year>2016</year>
          <fpage>1552</fpage>
          <lpage>1557</lpage>
          <pub-id pub-id-type="pmid">26811476</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <element-citation publication-type="journal" id="sref12">
          <person-group person-group-type="author">
            <name>
              <surname>Bourdeau</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Dumont</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Letarte</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>A murine model of hereditary hemorrhagic telangiectasia</article-title>
          <source>J.Â Clin. Invest.</source>
          <volume>104</volume>
          <year>1999</year>
          <fpage>1343</fpage>
          <lpage>1351</lpage>
          <pub-id pub-id-type="pmid">10562296</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <element-citation publication-type="journal" id="sref13">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Naik</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Pukac</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tsareva</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Parice</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Mahoney</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Crystal structure of BMP-9 and functional interactions with pro-region and receptors</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>280</volume>
          <year>2005</year>
          <fpage>25111</fpage>
          <lpage>25118</lpage>
          <pub-id pub-id-type="pmid">15851468</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <element-citation publication-type="journal" id="sref14">
          <person-group person-group-type="author">
            <name>
              <surname>Castonguay</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Werner</surname>
              <given-names>E.D.</given-names>
            </name>
            <name>
              <surname>Matthews</surname>
              <given-names>R.G.</given-names>
            </name>
            <name>
              <surname>Presman</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Mulivor</surname>
              <given-names>A.W.</given-names>
            </name>
            <name>
              <surname>Solban</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Sako</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Pearsall</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Underwood</surname>
              <given-names>K.W.</given-names>
            </name>
            <name>
              <surname>Seehra</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>286</volume>
          <year>2011</year>
          <fpage>30034</fpage>
          <lpage>30046</lpage>
          <pub-id pub-id-type="pmid">21737454</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <element-citation publication-type="journal" id="sref15">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>V.T.</given-names>
            </name>
            <name>
              <surname>Crispin</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Aricescu</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Harvey</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Nettleship</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Fennelly</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Boles</surname>
              <given-names>K.S.</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Stuart</surname>
              <given-names>D.I.</given-names>
            </name>
          </person-group>
          <article-title>Glycoprotein structural genomics: solving the glycosylation problem</article-title>
          <source>Structure</source>
          <volume>15</volume>
          <year>2007</year>
          <fpage>267</fpage>
          <lpage>273</lpage>
          <pub-id pub-id-type="pmid">17355862</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <element-citation publication-type="journal" id="sref16">
          <person-group person-group-type="author">
            <name>
              <surname>Cheifetz</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>BellÃ³n</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>CalÃ©s</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Vera</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Bernabeu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>MassaguÃ©</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Letarte</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Endoglin is a component of the transforming growth factor-Î² receptor system in human endothelial cells</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>267</volume>
          <year>1992</year>
          <fpage>19027</fpage>
          <lpage>19030</lpage>
          <pub-id pub-id-type="pmid">1326540</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <element-citation publication-type="journal" id="sref17">
          <person-group person-group-type="author">
            <name>
              <surname>David</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Mallet</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Mazerbourg</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Feige</surname>
              <given-names>J.-J.</given-names>
            </name>
            <name>
              <surname>Bailly</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells</article-title>
          <source>Blood</source>
          <volume>109</volume>
          <year>2007</year>
          <fpage>1953</fpage>
          <lpage>1961</lpage>
          <pub-id pub-id-type="pmid">17068149</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <element-citation publication-type="journal" id="sref18">
          <person-group person-group-type="author">
            <name>
              <surname>Diestel</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Resch</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Meinhardt</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Weiler</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hellmann</surname>
              <given-names>T.V.</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>T.D.</given-names>
            </name>
            <name>
              <surname>Nickel</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Eichler</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>Y.A.</given-names>
            </name>
          </person-group>
          <article-title>Identification of a Novel TGF-Î²-Binding Site in the Zona Pellucida C-terminal (ZP-C) Domain of TGF-Î²-Receptor-3 (TGFR-3)</article-title>
          <source>PLoS ONE</source>
          <volume>8</volume>
          <year>2013</year>
          <fpage>e67214</fpage>
          <pub-id pub-id-type="pmid">23826237</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <element-citation publication-type="journal" id="sref19">
          <person-group person-group-type="author">
            <name>
              <surname>Gallione</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Repetto</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Legius</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Rustgi</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Schelley</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Tejpar</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Drouin</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Westermann</surname>
              <given-names>C.J.J.</given-names>
            </name>
            <name>
              <surname>Marchuk</surname>
              <given-names>D.A.</given-names>
            </name>
          </person-group>
          <article-title>AÂ combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4)</article-title>
          <source>Lancet</source>
          <volume>363</volume>
          <year>2004</year>
          <fpage>852</fpage>
          <lpage>859</lpage>
          <pub-id pub-id-type="pmid">15031030</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <element-citation publication-type="journal" id="sref20">
          <person-group person-group-type="author">
            <name>
              <surname>Gougos</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Letarte</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Biochemical characterization of the 44G4 antigen from the HOON pre-B leukemic cell line</article-title>
          <source>J.Â Immunol.</source>
          <volume>141</volume>
          <year>1988</year>
          <fpage>1934</fpage>
          <lpage>1940</lpage>
          <pub-id pub-id-type="pmid">3262645</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <element-citation publication-type="journal" id="sref21">
          <person-group person-group-type="author">
            <name>
              <surname>Gougos</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Letarte</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line</article-title>
          <source>J.Â Immunol.</source>
          <volume>141</volume>
          <year>1988</year>
          <fpage>1925</fpage>
          <lpage>1933</lpage>
          <pub-id pub-id-type="pmid">3262644</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <element-citation publication-type="journal" id="sref22">
          <person-group person-group-type="author">
            <name>
              <surname>Gougos</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Letarte</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>265</volume>
          <year>1990</year>
          <fpage>8361</fpage>
          <lpage>8364</lpage>
          <pub-id pub-id-type="pmid">1692830</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <element-citation publication-type="book" id="sref23">
          <person-group person-group-type="author">
            <name>
              <surname>Gregory</surname>
              <given-names>A.L.</given-names>
            </name>
          </person-group>
          <chapter-title>Structural and Functional Characteristics of a Soluble Form of Endoglin in the Context of Preeclampsia. MSc</chapter-title>
          <year>2011</year>
          <publisher-name>University of Toronto</publisher-name>
        </element-citation>
      </ref>
      <ref id="bib24">
        <element-citation publication-type="journal" id="sref24">
          <person-group person-group-type="author">
            <name>
              <surname>Gregory</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Sotov</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Letarte</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Review: the enigmatic role of endoglin in the placenta</article-title>
          <source>Placenta</source>
          <volume>35</volume>
          <issue>Suppl</issue>
          <year>2014</year>
          <fpage>S93</fpage>
          <lpage>S99</lpage>
          <pub-id pub-id-type="pmid">24252708</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <element-citation publication-type="journal" id="sref25">
          <person-group person-group-type="author">
            <name>
              <surname>Guerrero-Esteo</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sanchez-Elsner</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Letamendia</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bernabeu</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-Î² receptors I and II</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>277</volume>
          <year>2002</year>
          <fpage>29197</fpage>
          <lpage>29209</lpage>
          <pub-id pub-id-type="pmid">12015308</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <element-citation publication-type="journal" id="sref26">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>MonnÃ©</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Okumura</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Schwend</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Cherry</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Flot</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Matsuda</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Jovine</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Insights into egg coat assembly and egg-sperm interaction from the X-ray structure of full-length ZP3</article-title>
          <source>Cell</source>
          <volume>143</volume>
          <year>2010</year>
          <fpage>404</fpage>
          <lpage>415</lpage>
          <pub-id pub-id-type="pmid">20970175</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <element-citation publication-type="journal" id="sref27">
          <person-group person-group-type="author">
            <name>
              <surname>Hawinkels</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Kuiper</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Wiercinska</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Verspaget</surname>
              <given-names>H.W.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Pardali</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Sier</surname>
              <given-names>C.F.</given-names>
            </name>
            <name>
              <surname>ten Dijke</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis</article-title>
          <source>Cancer Res.</source>
          <volume>70</volume>
          <year>2010</year>
          <fpage>4141</fpage>
          <lpage>4150</lpage>
          <pub-id pub-id-type="pmid">20424116</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <element-citation publication-type="journal" id="sref28">
          <person-group person-group-type="author">
            <name>
              <surname>Hinck</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>T.D.</given-names>
            </name>
            <name>
              <surname>Springer</surname>
              <given-names>T.A.</given-names>
            </name>
          </person-group>
          <article-title>Structural biology and evolution of the TGF-Î² family</article-title>
          <source>Cold Spring Harb. Perspect. Biol.</source>
          <volume>8</volume>
          <year>2016</year>
          <fpage>a022103</fpage>
          <pub-id pub-id-type="pmid">27638177</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <element-citation publication-type="journal" id="sref29">
          <person-group person-group-type="author">
            <name>
              <surname>Horbelt</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Denkis</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Knaus</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>A portrait of Transforming Growth Factor Î² superfamily signalling: Background matters</article-title>
          <source>Int. J. Biochem. Cell Biol.</source>
          <volume>44</volume>
          <year>2012</year>
          <fpage>469</fpage>
          <lpage>474</lpage>
          <pub-id pub-id-type="pmid">22226817</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <element-citation publication-type="journal" id="sref30">
          <person-group person-group-type="author">
            <name>
              <surname>Johnson</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Berg</surname>
              <given-names>J.N.</given-names>
            </name>
            <name>
              <surname>Baldwin</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Gallione</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Marondel</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Stenzel</surname>
              <given-names>T.T.</given-names>
            </name>
            <name>
              <surname>Speer</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Pericak-Vance</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Diamond</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2</article-title>
          <source>Nat. Genet.</source>
          <volume>13</volume>
          <year>1996</year>
          <fpage>189</fpage>
          <lpage>195</lpage>
          <pub-id pub-id-type="pmid">8640225</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <element-citation publication-type="journal" id="sref31">
          <person-group person-group-type="author">
            <name>
              <surname>Kienast</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Jucknischke</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Scheiblich</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Thier</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>de Wouters</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lehmann</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Brand</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Bernicke</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Honold</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Lorenz</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Rapid activation of bone morphogenic protein 9 by receptor-mediated displacement of pro-domains</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>291</volume>
          <year>2016</year>
          <fpage>3395</fpage>
          <lpage>3410</lpage>
          <pub-id pub-id-type="pmid">26677222</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <element-citation publication-type="journal" id="sref32">
          <person-group person-group-type="author">
            <name>
              <surname>Lebrin</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Goumans</surname>
              <given-names>M.-J.</given-names>
            </name>
            <name>
              <surname>Jonker</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>R.L.C.</given-names>
            </name>
            <name>
              <surname>Valdimarsdottir</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Thorikay</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mummery</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Arthur</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>ten Dijke</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Endoglin promotes endothelial cell proliferation and TGF-Î²/ALK1 signal transduction</article-title>
          <source>EMBO J.</source>
          <volume>23</volume>
          <year>2004</year>
          <fpage>4018</fpage>
          <lpage>4028</lpage>
          <pub-id pub-id-type="pmid">15385967</pub-id>
        </element-citation>
      </ref>
      <ref id="bib33">
        <element-citation publication-type="journal" id="sref33">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>D.Y.</given-names>
            </name>
            <name>
              <surname>Sorensen</surname>
              <given-names>L.K.</given-names>
            </name>
            <name>
              <surname>Brooke</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Urness</surname>
              <given-names>L.D.</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>E.C.</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Boak</surname>
              <given-names>B.B.</given-names>
            </name>
            <name>
              <surname>Wendel</surname>
              <given-names>D.P.</given-names>
            </name>
          </person-group>
          <article-title>Defective angiogenesis in mice lacking endoglin</article-title>
          <source>Science</source>
          <volume>284</volume>
          <year>1999</year>
          <fpage>1534</fpage>
          <lpage>1537</lpage>
          <pub-id pub-id-type="pmid">10348742</pub-id>
        </element-citation>
      </ref>
      <ref id="bib34">
        <element-citation publication-type="journal" id="sref34">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Woodruff</surname>
              <given-names>T.K.</given-names>
            </name>
            <name>
              <surname>Jardetzky</surname>
              <given-names>T.S.</given-names>
            </name>
          </person-group>
          <article-title>Structure of betaglycan zona pellucida (ZP)-C domain provides insights into ZP-mediated protein polymerization and TGF-Î² binding</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>108</volume>
          <year>2011</year>
          <fpage>5232</fpage>
          <lpage>5236</lpage>
          <pub-id pub-id-type="pmid">21402931</pub-id>
        </element-citation>
      </ref>
      <ref id="bib35">
        <element-citation publication-type="book" id="sref35">
          <person-group person-group-type="author">
            <name>
              <surname>Litscher</surname>
              <given-names>E.S.</given-names>
            </name>
            <name>
              <surname>Wassarman</surname>
              <given-names>P.M.</given-names>
            </name>
          </person-group>
          <chapter-title>A guide to zona pellucida domain proteins</chapter-title>
          <year>2015</year>
          <publisher-name>John Wiley &amp; Sons, Inc.</publisher-name>
          <publisher-loc>Hoboken, New Jersey</publisher-loc>
        </element-citation>
      </ref>
      <ref id="bib36">
        <element-citation publication-type="journal" id="sref36">
          <person-group person-group-type="author">
            <name>
              <surname>Llorca</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Trujillo</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Blanco</surname>
              <given-names>F.J.</given-names>
            </name>
            <name>
              <surname>Bernabeu</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia</article-title>
          <source>J.Â Mol. Biol.</source>
          <volume>365</volume>
          <year>2007</year>
          <fpage>694</fpage>
          <lpage>705</lpage>
          <pub-id pub-id-type="pmid">17081563</pub-id>
        </element-citation>
      </ref>
      <ref id="bib37">
        <element-citation publication-type="journal" id="sref37">
          <person-group person-group-type="author">
            <name>
              <surname>Mahlawat</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Ilangovan</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Biswas</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>L.Z.</given-names>
            </name>
            <name>
              <surname>Hinck</surname>
              <given-names>A.P.</given-names>
            </name>
          </person-group>
          <article-title>Structure of the Alk1 extracellular domain and characterization of its bone morphogenetic protein (BMP) binding properties</article-title>
          <source>Biochemistry</source>
          <volume>51</volume>
          <year>2012</year>
          <fpage>6328</fpage>
          <lpage>6341</lpage>
          <pub-id pub-id-type="pmid">22799562</pub-id>
        </element-citation>
      </ref>
      <ref id="bib38">
        <element-citation publication-type="journal" id="sref38">
          <person-group person-group-type="author">
            <name>
              <surname>Mallet</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Lamribet</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Giraud</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Dupuis-Girod</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Feige</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Bailly</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tillet</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Functional analysis of endoglin mutations from hereditary hemorrhagic telangiectasia type 1 patients reveals different mechanisms for endoglin loss of function</article-title>
          <source>Hum. Mol. Genet.</source>
          <volume>24</volume>
          <year>2015</year>
          <fpage>1142</fpage>
          <lpage>1154</lpage>
          <pub-id pub-id-type="pmid">25312062</pub-id>
        </element-citation>
      </ref>
      <ref id="bib39">
        <element-citation publication-type="journal" id="sref39">
          <person-group person-group-type="author">
            <name>
              <surname>McAllister</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Grogg</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Gallione</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Baldwin</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Helmbold</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Markel</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>McKinnon</surname>
              <given-names>W.C.</given-names>
            </name>
            <name>
              <surname>Murrell</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Endoglin, a TGF-Î² binding protein of endothelial cells, is theÂ gene for hereditary haemorrhagic telangiectasia type 1</article-title>
          <source>Nat. Genet.</source>
          <volume>8</volume>
          <year>1994</year>
          <fpage>345</fpage>
          <lpage>351</lpage>
          <pub-id pub-id-type="pmid">7894484</pub-id>
        </element-citation>
      </ref>
      <ref id="bib40">
        <element-citation publication-type="journal" id="sref40">
          <person-group person-group-type="author">
            <name>
              <surname>Mi</surname>
              <given-names>L.Z.</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>C.T.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Le</surname>
              <given-names>V.Q.</given-names>
            </name>
            <name>
              <surname>Walz</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Springer</surname>
              <given-names>T.A.</given-names>
            </name>
          </person-group>
          <article-title>Structure of bone morphogenetic protein 9 procomplex</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>112</volume>
          <year>2015</year>
          <fpage>3710</fpage>
          <lpage>3715</lpage>
          <pub-id pub-id-type="pmid">25751889</pub-id>
        </element-citation>
      </ref>
      <ref id="bib41">
        <element-citation publication-type="journal" id="sref41">
          <person-group person-group-type="author">
            <name>
              <surname>Miller</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Graulich</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Karges</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Stahl</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ernst</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ramaswamy</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sedlacek</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>MÃ¼ller</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Adamkiewicz</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Elevated expression of endoglin, a component of the TGF-Î²-receptor complex, correlates with proliferation of tumor endothelial cells</article-title>
          <source>Int. J. Cancer</source>
          <volume>81</volume>
          <year>1999</year>
          <fpage>568</fpage>
          <lpage>572</lpage>
          <pub-id pub-id-type="pmid">10225446</pub-id>
        </element-citation>
      </ref>
      <ref id="bib42">
        <element-citation publication-type="journal" id="sref42">
          <person-group person-group-type="author">
            <name>
              <surname>Nithianantham</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Le</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Seto</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Jia</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Leary</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Corbett</surname>
              <given-names>K.D.</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Al-Bassam</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Tubulin cofactors and Arl2 are cage-like chaperones that regulate the soluble Î±Î²-tubulin pool for microtubule dynamics</article-title>
          <source>eLife</source>
          <volume>4</volume>
          <year>2015</year>
          <fpage>e08811</fpage>
        </element-citation>
      </ref>
      <ref id="bib43">
        <element-citation publication-type="journal" id="sref43">
          <person-group person-group-type="author">
            <name>
              <surname>Nolan-Stevaux</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Zhong</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Culp</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Shaffer</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hoover</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wickramasinghe</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ruefli-Brasse</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Endoglin requirement for BMP9 signaling in endothelial cells reveals new mechanism of action for selective anti-endoglin antibodies</article-title>
          <source>PLoS ONE</source>
          <volume>7</volume>
          <year>2012</year>
          <fpage>e50920</fpage>
          <pub-id pub-id-type="pmid">23300529</pub-id>
        </element-citation>
      </ref>
      <ref id="bib44">
        <element-citation publication-type="journal" id="sref44">
          <person-group person-group-type="author">
            <name>
              <surname>Ohta</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Greenberger</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Anklesaria</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bassols</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>MassaguÃ©</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Two forms of transforming growth factor-Î² distinguished by multipotential haematopoietic progenitor cells</article-title>
          <source>Nature</source>
          <volume>329</volume>
          <year>1987</year>
          <fpage>539</fpage>
          <lpage>541</lpage>
          <pub-id pub-id-type="pmid">2889143</pub-id>
        </element-citation>
      </ref>
      <ref id="bib45">
        <element-citation publication-type="journal" id="sref45">
          <person-group person-group-type="author">
            <name>
              <surname>Paauwe</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Heijkants</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Oudt</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>van Pelt</surname>
              <given-names>G.W.</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Theuer</surname>
              <given-names>C.P.</given-names>
            </name>
            <name>
              <surname>Hardwick</surname>
              <given-names>J.C.H.</given-names>
            </name>
            <name>
              <surname>Sier</surname>
              <given-names>C.F.M.</given-names>
            </name>
            <name>
              <surname>Hawinkels</surname>
              <given-names>L.J.A.C.</given-names>
            </name>
          </person-group>
          <article-title>Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer</article-title>
          <source>Oncogene</source>
          <volume>35</volume>
          <year>2016</year>
          <fpage>4069</fpage>
          <lpage>4079</lpage>
          <pub-id pub-id-type="pmid">26804178</pub-id>
        </element-citation>
      </ref>
      <ref id="bib46">
        <element-citation publication-type="journal" id="sref46">
          <person-group person-group-type="author">
            <name>
              <surname>Paquet</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Pece-Barbara</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Vera</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cymerman</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Karabegovic</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Shovlin</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Letarte</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function</article-title>
          <source>Hum. Mol. Genet.</source>
          <volume>10</volume>
          <year>2001</year>
          <fpage>1347</fpage>
          <lpage>1357</lpage>
          <pub-id pub-id-type="pmid">11440987</pub-id>
        </element-citation>
      </ref>
      <ref id="bib47">
        <element-citation publication-type="journal" id="sref47">
          <person-group person-group-type="author">
            <name>
              <surname>Pece-Barbara</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Cymerman</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Vera</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Marchuk</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Letarte</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1</article-title>
          <source>Hum. Mol. Genet.</source>
          <volume>8</volume>
          <year>1999</year>
          <fpage>2171</fpage>
          <lpage>2181</lpage>
          <pub-id pub-id-type="pmid">10545596</pub-id>
        </element-citation>
      </ref>
      <ref id="bib48">
        <element-citation publication-type="journal" id="sref48">
          <person-group person-group-type="author">
            <name>
              <surname>Quackenbush</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Letarte</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies</article-title>
          <source>J.Â Immunol.</source>
          <volume>134</volume>
          <year>1985</year>
          <fpage>1276</fpage>
          <lpage>1285</lpage>
          <pub-id pub-id-type="pmid">3155538</pub-id>
        </element-citation>
      </ref>
      <ref id="bib49">
        <element-citation publication-type="journal" id="sref49">
          <person-group person-group-type="author">
            <name>
              <surname>Reeves</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Callewaert</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Contreras</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Khorana</surname>
              <given-names>H.G.</given-names>
            </name>
          </person-group>
          <article-title>Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>99</volume>
          <year>2002</year>
          <fpage>13419</fpage>
          <lpage>13424</lpage>
          <pub-id pub-id-type="pmid">12370423</pub-id>
        </element-citation>
      </ref>
      <ref id="bib50">
        <element-citation publication-type="journal" id="sref50">
          <person-group person-group-type="author">
            <name>
              <surname>Rossi</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Lopez-Novoa</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Bernabeu</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Endoglin involvement in integrin-mediated cell adhesion as a putative pathogenic mechanism in hereditary hemorrhagic telangiectasia type 1 (HHT1)</article-title>
          <source>Front. Genet.</source>
          <volume>5</volume>
          <year>2015</year>
          <fpage>457</fpage>
          <pub-id pub-id-type="pmid">25709613</pub-id>
        </element-citation>
      </ref>
      <ref id="bib51">
        <element-citation publication-type="journal" id="sref51">
          <person-group person-group-type="author">
            <name>
              <surname>Scharpfenecker</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>van Dinther</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>van Bezooijen</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Pukac</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>LÃ¶wik</surname>
              <given-names>C.W.G.M.</given-names>
            </name>
            <name>
              <surname>ten Dijke</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis</article-title>
          <source>J.Â Cell Sci.</source>
          <volume>120</volume>
          <year>2007</year>
          <fpage>964</fpage>
          <lpage>972</lpage>
          <pub-id pub-id-type="pmid">17311849</pub-id>
        </element-citation>
      </ref>
      <ref id="bib52">
        <element-citation publication-type="journal" id="sref52">
          <person-group person-group-type="author">
            <name>
              <surname>She</surname>
              <given-names>X.W.</given-names>
            </name>
            <name>
              <surname>Seon</surname>
              <given-names>B.K.</given-names>
            </name>
          </person-group>
          <article-title>Epitope mapping of endoglin, a TGF-Î² receptor, using recombinant fragments and twelve monoclonal antibodies</article-title>
          <source>Proc. Am. Assoc. Cancer Res.</source>
          <volume>42</volume>
          <year>2001</year>
          <fpage>825</fpage>
        </element-citation>
      </ref>
      <ref id="bib53">
        <element-citation publication-type="journal" id="sref53">
          <person-group person-group-type="author">
            <name>
              <surname>Stenson</surname>
              <given-names>P.D.</given-names>
            </name>
            <name>
              <surname>Mort</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ball</surname>
              <given-names>E.V.</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>D.N.</given-names>
            </name>
          </person-group>
          <article-title>The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine</article-title>
          <source>Hum. Genet.</source>
          <volume>133</volume>
          <year>2014</year>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">24077912</pub-id>
        </element-citation>
      </ref>
      <ref id="bib54">
        <element-citation publication-type="journal" id="sref54">
          <person-group person-group-type="author">
            <name>
              <surname>Townson</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Martinez-Hackert</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Greppi</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Lowden</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Sako</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ucran</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Liharska</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Underwood</surname>
              <given-names>K.W.</given-names>
            </name>
            <name>
              <surname>Seehra</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>287</volume>
          <year>2012</year>
          <fpage>27313</fpage>
          <lpage>27325</lpage>
          <pub-id pub-id-type="pmid">22718755</pub-id>
        </element-citation>
      </ref>
      <ref id="bib55">
        <element-citation publication-type="journal" id="sref55">
          <person-group person-group-type="author">
            <name>
              <surname>Upton</surname>
              <given-names>P.D.</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Trembath</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Morrell</surname>
              <given-names>N.W.</given-names>
            </name>
          </person-group>
          <article-title>Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>284</volume>
          <year>2009</year>
          <fpage>15794</fpage>
          <lpage>15804</lpage>
          <pub-id pub-id-type="pmid">19366699</pub-id>
        </element-citation>
      </ref>
      <ref id="bib56">
        <element-citation publication-type="journal" id="sref56">
          <person-group person-group-type="author">
            <name>
              <surname>Van Le</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Franke</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Svergun</surname>
              <given-names>D.I.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>H.Y.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>K.K.</given-names>
            </name>
          </person-group>
          <article-title>Structural and functional characterization of soluble endoglin receptor</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <volume>383</volume>
          <year>2009</year>
          <fpage>386</fpage>
          <lpage>391</lpage>
          <pub-id pub-id-type="pmid">19268655</pub-id>
        </element-citation>
      </ref>
      <ref id="bib57">
        <element-citation publication-type="journal" id="sref57">
          <person-group person-group-type="author">
            <name>
              <surname>Venkatesha</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Toporsian</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hanai</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Mammoto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>Y.M.</given-names>
            </name>
            <name>
              <surname>Bdolah</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>K.H.</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>H.T.</given-names>
            </name>
            <name>
              <surname>Libermann</surname>
              <given-names>T.A.</given-names>
            </name>
          </person-group>
          <article-title>Soluble endoglin contributes to the pathogenesis of preeclampsia</article-title>
          <source>Nat. Med.</source>
          <volume>12</volume>
          <year>2006</year>
          <fpage>642</fpage>
          <lpage>649</lpage>
          <pub-id pub-id-type="pmid">16751767</pub-id>
        </element-citation>
      </ref>
      <ref id="bib58">
        <element-citation publication-type="journal" id="sref58">
          <person-group person-group-type="author">
            <name>
              <surname>Wooderchak-Donahue</surname>
              <given-names>W.L.</given-names>
            </name>
            <name>
              <surname>McDonald</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>OâFallon</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Upton</surname>
              <given-names>P.D.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Roman</surname>
              <given-names>B.L.</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Plant</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>FÃ¼lÃ¶p</surname>
              <given-names>G.T.</given-names>
            </name>
            <name>
              <surname>Langa</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia</article-title>
          <source>Am. J. Hum. Genet.</source>
          <volume>93</volume>
          <year>2013</year>
          <fpage>530</fpage>
          <lpage>537</lpage>
          <pub-id pub-id-type="pmid">23972370</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="app1">
      <title>Accession Numbers</title>
      <p>The accession numbers for the atomic coordinates and structure factors for human ENG OR, BMP9, the ENG OR-BMP9 complex, and ENG ZP reported in this paper are PDB: <ext-link ext-link-type="uri" xlink:href="pdb:5I04" id="intref0030">5I04</ext-link>, <ext-link ext-link-type="uri" xlink:href="pdb:5I05" id="intref0035">5I05</ext-link>, <ext-link ext-link-type="uri" xlink:href="pdb:5HZW" id="intref0040">5HZW</ext-link>, and <ext-link ext-link-type="uri" xlink:href="pdb:5HZV" id="intref0045">5HZV</ext-link>, respectively.</p>
    </sec>
    <sec id="app3" sec-type="supplementary-material">
      <title>Supplemental Information</title>
      <p>
        <supplementary-material content-type="local-data" id="mmc1">
          <caption>
            <title>Document S1. Supplemental Experimental Procedures, Figures S1âS8, and Table S1</title>
          </caption>
          <media xlink:href="mmc1.pdf"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="mmc2">
          <caption>
            <title>Document S2. Article plus Supplemental Information</title>
          </caption>
          <media xlink:href="mmc2.pdf"/>
        </supplementary-material>
      </p>
    </sec>
    <ack id="ack0010">
      <title>Acknowledgments</title>
      <p>We thank A. Gregory (University of Toronto) for initial work on this project, K. Nishimura (Karolinska Institutet) and M. Selmer (Uppsala University) for help with BMP9 expression and data collection, A. Stsiapanava (Karolinska Institutet) for comments, and the European Synchrotron Radiation Facility (ESRF, Grenoble) and Diamond Light Source (DLS, Oxford) for beamtime (ESRF, mx1639/mx1749; DLS, mx8492-34). We are also extremely grateful to Edwin de Grijs and Tim Heiseler (PALL FortÃ©Bio) for help with BLI measurements and Christoph Albermann and Christian Ackerschott (Wyatt Technology Europe) for SEC-MALS analysis. This work was supported by the <funding-source id="gs1">Karolinska Institutet</funding-source>, the <funding-source id="gs2">Center for Innovative Medicine</funding-source>, <funding-source id="gs3">Swedish Research Council</funding-source> grant 2012-5093, the <funding-source id="gs4">GÃ¶ran Gustafsson Foundation for Research in Natural Sciences and Medicine</funding-source>, the <funding-source id="gs5">Sven and Ebba-Christina Hagberg Foundation</funding-source>; an <funding-source id="gs6">EMBO</funding-source> Young Investigator award, and the <funding-source id="gs7">European Research Council</funding-source> (ERC) under the <funding-source id="gs8">European Unionâs Seventh Framework Programme</funding-source> (FP7/2007-2013)/ERC grant agreement 260759 (to L.J.). Crystallographic data collection was also supported by FP7/2007-2013 under <funding-source id="gs9">BioStruct-X</funding-source> (grant agreement 283570).</p>
    </ack>
    <fn-group>
      <fn id="app2" fn-type="supplementary-material">
        <p>Supplemental Information includes Supplemental Experimental Procedures, eight figures, and one table and can be found with this article online at <ext-link ext-link-type="doi" xlink:href="10.1016/j.celrep.2017.05.011" id="intref0050">http://dx.doi.org/10.1016/j.celrep.2017.05.011</ext-link>.</p>
      </fn>
    </fn-group>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>